MedTrace Logo

Study on the Pharmacokinetics of Bromine Hexane Hydrochloride Tablets in Healthy Adults

NCT04672707 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2025-05-16

No results posted yet for this study

Summary

This clinical study is about increasing the dosage of bromine hexane hydrochloride to safety volume and continue to give it frequently in the new crown virus treatment could improve the efficacy.

Conditions

  • Pharmacokinetics

Interventions

DRUG

Bromhexine Hydrochloride Tablet

32 mg

DRUG

Bromhexine Hydrochloride Tablet

48 mg

DRUG

Bromhexine Hydrochloride Tablet

64 mg

DRUG

Bromhexine Hydrochloride Tablet

80mg

Sponsors & Collaborators

  • Wanbangde Pharmaceutical Group Co., LTD

    collaborator INDUSTRY

  • Second Affiliated Hospital of Wenzhou Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-28
Primary Completion
2024-07-02
Completion
2024-07-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04672707 on ClinicalTrials.gov